JP Morgan Chase
RXL icon

JP Morgan Chase’s ProShares Ultra Health Care RXL Stock Holding History

JP Morgan Chase’s Portfolio RXL Stock Details RXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-916
Closed -$39K – 7277
2023
Q1 		$39K Buy
+916
New +$40.1K ﹤0.01% 5797
2021
Q4 		– Sell
-40
Closed -$2K – 6919
2021
Q3 		$2K Buy
+40
New +$2.04K ﹤0.01% 6340
2020
Q1 		– Sell
-908
Closed -$29K – 5667
2019
Q4 		$29K Hold
908
– – ﹤0.01% 5259
2019
Q3 		$22K Sell
908
-108
-11% -$2.75K ﹤0.01% 5395
2019
Q2 		$26K Buy
+1,016
New +$25.2K ﹤0.01% 5396

Other funds holding RXL

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PFA
Plotkin Financial Advisors Chevy Chase, Maryland $199M AUM 19.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

JP Morgan Chase's RXL Position: Q2 2023 in Review

JP Morgan Chase sold out of ProShares Ultra Health Care (RXL) in Q2 2023, closing a stake of 916 shares — an estimated $39K sold.

JP Morgan Chase first reported a position in RXL in Q2 2019 and held it in 5 quarters. The position peaked at $39K in Q1 2023. 17 funds tracked by Wall St. Rank hold RXL as of Q2 2023.

  • JP Morgan Chase reported no remaining ProShares Ultra Health Care position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Chase sold 916 ProShares Ultra Health Care shares in Q2 2023, an estimated $39K.
  • JP Morgan Chase first reported a position in ProShares Ultra Health Care in Q2 2019 and held it in 5 quarters.
  • JP Morgan Chase's ProShares Ultra Health Care position peaked at $39K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.